@misc{indiciae673aa7984aa8,
  title = {Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.},
  author = {Michael Tveden Gundesen and Annette Juul Vangsted and Carsten Helleberg and Einar Hauk\&\#xe5;s and Trine Silkj\&\#xe6;r and Jonna Skov Madsen and Jon Thor Asmussen and Elena Manuela Teodorescu and Bo Amdi Jensen and Tobias Schmidt Sl\&\#xf8;rdahl and Aneta Alexandra Nielsen and Dorte Aalund Olsen and Kent S\&\#xf8;e and Hareth Nahi and Anders Waage and Niels Abildgaard and Fredrik Schjesvold and Thomas Lund},
  year = {2026},
  doi = {10.1111/bjh.70612},
  url = {https://pubmed.ncbi.nlm.nih.gov/42581608/},
  note = {Source identifier: 42581608}
}